NCT03692676View on ClinicalTrials.gov

Characteristics of Pts Initiating Spiriva Respimat in Asthma

CompletedOBSERVATIONAL
Enrollment

116,133

Participants

Timeline

Start Date

March 5, 2019

Primary Completion Date

October 11, 2019

Study Completion Date

October 11, 2019

Conditions
Asthma
Interventions
DEVICE

Spiriva Respimat

soft-mist inhaler

Trial Locations (1)

Unknown

Boehringer Ingelheim, Ingelheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03692676 - Characteristics of Pts Initiating Spiriva Respimat in Asthma | Biotech Hunter | Biotech Hunter